122 related articles for article (PubMed ID: 12195758)
21. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
[TBL] [Abstract][Full Text] [Related]
22. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
Lorvidhaya V; Chitapanarux I; Sangruchi S; Lertsanguansinchai P; Kongthanarat Y; Tangkaratt S; Visetsiri E
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1226-32. PubMed ID: 12654431
[TBL] [Abstract][Full Text] [Related]
23. Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
Riva C; Lavieille JP; Schmerber S; Cuisnie O; Reyt E
Int J Oncol; 2000 Sep; 17(3):543-9. PubMed ID: 10938396
[TBL] [Abstract][Full Text] [Related]
24. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
[TBL] [Abstract][Full Text] [Related]
25. Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimen.
Tomasello G; Chiesa MD; Buti S; Brighenti M; Negri F; Rovere RK; Martinotti M; Buononato M; Brunelli A; Lazzarelli S; Donati G; Passalacqua R
Tumori; 2010; 96(1):48-53. PubMed ID: 20437857
[TBL] [Abstract][Full Text] [Related]
26. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
Kucuk O; Shevrin DH; Pandya KJ; Bonomi PD
Am J Clin Oncol; 2000 Aug; 23(4):371-5. PubMed ID: 10955866
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.
Chambers SK; Lamb L; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1994 May; 53(2):161-9. PubMed ID: 7514557
[TBL] [Abstract][Full Text] [Related]
29. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis.
Di Lorenzo G; Buonerba C; Federico P; Perdonà S; Aieta M; Rescigno P; D'Aniello C; Puglia L; Petremolo A; Ferro M; Marinelli A; Palmieri G; Sonpavde G; Mirone V; De Placido S
BJU Int; 2012 Dec; 110(11 Pt B):E661-6. PubMed ID: 22958571
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma.
Aoki Y; Sato T; Watanabe M; Sasaki M; Tsuneki I; Tanaka K
Gynecol Oncol; 2001 Jun; 81(3):496-9. PubMed ID: 11371145
[TBL] [Abstract][Full Text] [Related]
32. Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: a phase II study.
Nolè F; Munzone E; Mandalà M; Catania C; Orlando L; Zampino MG; Minchella I; Colleoni M; Peruzzotti G; Marrocco E; Goldhirsch A
Ann Oncol; 2001 Jan; 12(1):95-100. PubMed ID: 11249057
[TBL] [Abstract][Full Text] [Related]
33. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
34. [Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]].
Nguyen D; de la Rochefordière A; Chauveinc L; Cosset JM; Clough KB; Beuzeboc P; Mouret-Fourme E; Guyonnet M
Cancer Radiother; 2002 Jun; 6(4):201-8. PubMed ID: 12224486
[TBL] [Abstract][Full Text] [Related]
35. A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer.
Miglietta L; Franzone P; Centurioni MG; Boni L; Tacchini L; Cosso M; Boccardo F; Ferrarini M; Bruzzone M
Oncology; 2006; 70(1):19-24. PubMed ID: 16439862
[TBL] [Abstract][Full Text] [Related]
36. Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.
Schöffski P; Catimel G; Planting AS; Droz JP; Verweij J; Schrijvers D; Gras L; Schrijvers A; Wanders J; Hanauske AR
Ann Oncol; 1999 Jan; 10(1):119-22. PubMed ID: 10076732
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
Hussain M; Gadgeel S; Kucuk O; Du W; Salwen W; Ensley J
Cancer; 1999 Dec; 86(11):2364-9. PubMed ID: 10590379
[TBL] [Abstract][Full Text] [Related]
38. A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer.
Kollmannsberger C; Quietzsch D; Haag C; Lingenfelser T; Schroeder M; Hartmann JT; Baronius W; Hempel V; Clemens M; Kanz L; Bokemeyer C
Br J Cancer; 2000 Aug; 83(4):458-62. PubMed ID: 10945491
[TBL] [Abstract][Full Text] [Related]
39. Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer.
Natoli C; Scognamiglio MT; Martino MT; Irtelli L; De Tursi M; Cianchetti E; Mascitelli E; Tinari N; Iacobelli S
Anticancer Res; 2000; 20(2B):1253-6. PubMed ID: 10810430
[TBL] [Abstract][Full Text] [Related]
40. Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
Penson RT; Huang HQ; Wenzel LB; Monk BJ; Stockman S; Long HJ; Ramondetta LM; Landrum LM; Oaknin A; Reid TJ; Leitao MM; Method M; Michael H; Tewari KS
Lancet Oncol; 2015 Mar; 16(3):301-11. PubMed ID: 25638326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
